Clinical Validation and Market Access for Medical Devices in Southeast Asia
Value Proposition
Early traction in healthtech isn't about praise. It's about proof. The healthcare buyers aren't just evaluating product features - they're evaluating credibility. And credibility isn't built through user love. It's built through real proof.
Cost control in health insurance is the most pressing and universal need for healthcare providers worldwide. Without compromising the quality of care, only technological innovation can enable the delivery of more cost-effective and higher-value medical services to the general patient population.
The Med-Map team supports medical device and IVD companies in navigating clinical validation and building sustainable market access across Southeast Asia. Primary focus regions: Singapore · Malaysia · Thailand · Indonesia · Vietnam
Here are the key business services we provided for a new Medical Product:
Market Assessment
- Understand the specific healthcare needs and gaps in regional market. Identify areas where the medical product can make a significant impact.
- Competitor Research & Insight in the targeted market.
- Deliver strategic consulting for market-entry strategy and business development.
Clinical Validation
- KOL partnerships.
- The healthcare buyers don't need the local clinical trial for all the product. But they do need local clinical validation evidence.
- Start with evidence, not excitement. Engage with local hospitals and clinical institutions to validate the safety and efficacy of the product.
Regulatory Compliance
- Navigate the regulatory landscape. Obtain necessary approvals, certifications, and licenses for the product.
- Collaborate with local health authorities to ensure compliance with national regulations.
Distribution Network Establishment
- Identify Distribution Channels.
- Establish partnerships with local distributors and logistics providers.
- Ensure efficient supply chain management for timely product availability.
Market Entry Strategy
- Define pricing strategies based on market research and competitor analysis.
- Develop marketing campaigns to create awareness among healthcare providers.
Who This Service Is For?
This service is designed for:
Medical device and IVD manufacturers entering Southeast Asia
AI / software as a medical device (SaMD) company
Medical Imaging, diagnostics, and digital health companies
Companies preparing for HSA, MDA, or regional regulatory submissions
Firms seeking local clinical validation sites and commercial channels
What We Deliver
We provide end-to-end execution, not just advisory.
Clinical Validation
- Clinical evidence gap analysis
- Clinical evaluation / performance evaluation planning
- Local clinical validation studies (IVD, imaging, SaMD)
- Study site and KOL coordination
- Data readiness for regulatory submission
Market Access & Channel Development
- Market entry strategy for Southeast Asia
- Country-specific regulatory pathway mapping
- Distributor identification and qualification
- Channel strategy design and rollout support
- Early commercialization and pilot deployment
Why MedMap?
Deep understanding of clinical validation + commercialization as one system
Regional execution capability across Southeast Asia
Experience with complex, emerging technologies (AI, imaging, diagnostics)
Bridge between clinical evidence, regulation, and real-world adoption
3 Reasons to Partner With Us
Strategic Territorial Coverage
Southeast Asia (SEA)
Proven Track Records
Bringing innovative medical products to market in Southeast Asia, delivering value and impact to healthcare providers.
Uninterrupted Technical Support
By delivering timely local support, our localized technical support engineers minimize the need for costly overseas travel and build a strong trust among customers.
Our Regional Advantage
Southeast Asia is not a single market. Each country differs in:
We operate with on-the-ground regional execution capability, not a one-size-fits-all consulting model.
Typical Engagement Process
Scope & Readiness Assessment
Clinical evidence, regulatory status, and market objectives
Validation Strategy Design
Country-specific clinical validation and evidence plan
Local Execution
Clinical sites, KOLs, data collection, and coordination
Regulatory & Market Alignment
Support submission readiness and channel onboarding
Market Launch Support
Pilot programs, early adopters, and feedback loop
Scope & Readiness Assessment
Clinical evidence, regulatory status, and market objectives
Validation Strategy Design
Country-specific clinical validation and evidence plan
Local Execution
Clinical sites, KOLs, data collection, and coordination
Regulatory & Market Alignment
Support submission readiness and channel onboarding
Market Launch Support
Pilot programs, early adopters, and feedback loop
Key Regions & Pathways We Support
Singapore
HSA clinical evaluation and performance evidence pathways
Malaysia
MDA clinical validation and local study requirements
Thailand
Thai FDA evidence expectations
Indonesia
Market entry and channel structuring
Vietnam
Market entry and channel structuring
FAQ
We are not a traditional CRO. We operate as an execution partner integrating clinical validation, regulatory readiness, and market access.
Yes. We frequently support products at pre-registration or early validation stages.
Yes, through established regional clinical and industry networks.
ESTABLISH PARTNERSHIPS WITH DISTRIBUTORS
ESTABLISH PARTNERSHIPS WITH
DISTRIBUTORS
We offer finding the right distributors by expanding market reach, optimizing distribution processes, and leveraging the expertise of distribution specialists
We do establish relationships with influencers for launching a new product. We will establish a relationships with influencers to promote the products
Med-map provide businesses who need assistance with the process of registering their products with relevant regulatory authorities or government agencies.
Our Collaborators
